Literature DB >> 22160825

Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation.

Alain M Ngoma1, Kazuhiko Ikeda, Yuko Hashimoto, Kazuhiro Mochizuki, Hiroshi Takahashi, Hideki Sano, Hayato Matsumoto, Hideyoshi Noji, Syunnichi Saito, Atsushi Kikuta, Kazuei Ogawa, Mikio Ohtsuka, Masafumi Abe, Kenneth E Nollet, Hitoshi Ohto.   

Abstract

To elucidate the correlation between regulatory T cells (Tregs) and acute graft-versus-host disease (aGVHD) or cytomegalovirus infection following allogeneic bone marrow transplantation (allo-BMT), we evaluated either CD4⁺CD25(high) or FOXP3⁺ Treg-enriched cells in peripheral blood (PB) from 20 patients who received allo-BMT, and in biopsies of skin with aGVHD. Proportions of CD4⁺CD25(high)FOXP3⁺ cells in total lymphocytes, but not other types of T cells, were lower in patients who eventually developed grades II-IV aGVHD (n = 13) than in others (n = 7, P < 0.001). Proportions of CD62L⁺ cells in CD4⁺CD25(high) cells at day +30 were lower (P < 0.01) in patients who eventually showed cytomegalovirus viremia (n = 6) than in others (n = 14). Incidence of aGVHD (P < 0.05) or cytomegalovirus viremia (P < 0.05) was higher in patients without these complications, but with lower proportions of PB CD4⁺CD25(high)FOXP3⁺ cells at day +30 (n = 8) than in others (n = 8). However, in skin with aGVHD (n = 5), there was marked or slightly increased infiltration of CD8⁺ cells (P < 0.001) or CD3⁺FOXP3⁺ cells (P < 0.05), respectively, when compared with control (n = 5), resulting in threefold higher ratio of CD8⁺/CD3⁺FOXP3⁺ cells in aGVHD relative to controls (P < 0.05). Thus, impaired reconstitution of Tregs may be associated with aGVHD and CMV infection. Moreover, imbalance of Tregs and CD8⁺ cells may play a role in aGVHD tissue.

Entities:  

Mesh:

Year:  2011        PMID: 22160825     DOI: 10.1007/s12185-011-0976-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  35 in total

1.  Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.

Authors:  A M Thornton; E M Shevach
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Recovery of CMV-specific CD8+ T cells and Tregs after allogeneic peripheral blood stem cell transplantation.

Authors:  Domenico Pastore; Mario Delia; Anna Mestice; Tommasina Perrone; Paola Carluccio; Francesco Gaudio; Annamaria Giordano; Antonella Russo Rossi; Alessandra Ricco; Manuela Leo; Vincenzo Liso; Giorgina Specchia
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-10       Impact factor: 5.742

3.  Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

Authors:  Kathrin Rieger; Christoph Loddenkemper; Jochem Maul; Thomas Fietz; Daniel Wolff; Harald Terpe; Beate Steiner; Erika Berg; Stephan Miehlke; Martin Bornhäuser; Thomas Schneider; Martin Zeitz; Harald Stein; Eckhard Thiel; Rainer Duchmann; Lutz Uharek
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

4.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

5.  Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.

Authors:  Véronique Meignin; Régis Peffault de Latour; Julien Zuber; Armelle Régnault; Nicolas Mounier; Fabrice Lemaître; Hélène Dastot; Raphaël Itzykson; Agnès Devergie; Ana Cumano; Eliane Gluckman; Anne Janin; Antonio Bandeira; Gérard Socié
Journal:  Exp Hematol       Date:  2005-08       Impact factor: 3.084

6.  Association of Foxp3 regulatory gene expression with graft-versus-host disease.

Authors:  Yuji Miura; Christopher J Thoburn; Emilie C Bright; Michele L Phelps; Tahiro Shin; Elizabeth C Matsui; William H Matsui; Sally Arai; Ephraim J Fuchs; Georgia B Vogelsang; Richard J Jones; Allan D Hess
Journal:  Blood       Date:  2004-06-01       Impact factor: 22.113

7.  Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.

Authors:  Paul J Martin; Ji Pei; Ted Gooley; Claudio Anasetti; Frederick R Appelbaum; Joachim Deeg; John A Hansen; Richard A Nash; Effie W Petersdorf; Rainer Storb; Victor Ghetie; John Schindler; Ellen S Vitetta
Journal:  Biol Blood Marrow Transplant       Date:  2004-08       Impact factor: 5.742

Review 8.  Immunoregulatory T cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Curr Opin Immunol       Date:  2004-04       Impact factor: 7.486

9.  CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.

Authors:  Marta Stanzani; Sergio L R Martins; Rima M Saliba; Lisa S St John; Susan Bryan; Daniel Couriel; John McMannis; Richard E Champlin; Jeffrey J Molldrem; Krishna V Komanduri
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

10.  Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Martin E Dorf; Engin Ozkaynak; Wayne W Hancock
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

View more
  10 in total

1.  Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Satoshi Iyama; Kazuyuki Murase; Tsutomu Sato; Akari Hashimoto; Ayumi Tatekoshi; Hiroto Horiguchi; Yusuke Kamihara; Kaoru Ono; Shohei Kikuchi; Kohichi Takada; Yutaka Kawano; Tsuyoshi Hayashi; Koji Miyanishi; Yasushi Sato; Rishu Takimoto; Masayoshi Kobune; Satoru Mori; Junji Kato; Toshiharu Yamashita; Junji Kato
Journal:  Int J Hematol       Date:  2014-02-21       Impact factor: 2.490

2.  Persistent complete remission of acute leukemic-phase CCR4-positive gamma-delta peripheral T-cell lymphoma by autologous stem cell transplantation with mogamulizumab.

Authors:  Miki Furukawa; Kazuhiko Ikeda; Hiroshi Ohkawara; Shunichi Saito; Hiroshi Takahashi; Koki Ueda; Hayato Matsumoto; Yuko Hashimoto; Hitoshi Ohto; Kazuei Ogawa; Yasuchika Takeishi
Journal:  Int J Hematol       Date:  2015-05-15       Impact factor: 2.319

Review 3.  Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis.

Authors:  Leonn Mendes Soares Pereira; Samara Tatielle Monteiro Gomes; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Front Immunol       Date:  2017-05-26       Impact factor: 7.561

4.  A possible role of low regulatory T cells in anti-acetylcholine receptor antibody positive myasthenia gravis after bone marrow transplantation.

Authors:  Masahiko Fukatsu; Takenobu Murakami; Hiroshi Ohkawara; Shunichi Saito; Kazuhiko Ikeda; Suguru Kadowaki; Itaru Sasaki; Mari Segawa; Tomoko Soeda; Akihiko Hoshi; Hiroshi Takahashi; Akiko Shichishima-Nakamura; Kazuei Ogawa; Yoshihiro Sugiura; Hitoshi Ohto; Yasuchika Takeishi; Takayuki Ikezoe; Yoshikazu Ugawa
Journal:  BMC Neurol       Date:  2017-05-15       Impact factor: 2.474

5.  Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation.

Authors:  Jing-Rui Zhou; Da-Yu Shi; Rong Wei; Yu Wang; Chen-Hua Yan; Xiao-Hui Zhang; Lan-Ping Xu; Kai-Yan Liu; Xiao-Jun Huang; Yu-Qian Sun
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

Review 6.  Regulatory T cells in inflammation and resolution of acute lung injury.

Authors:  Linlin Wang; Weipeng Jiang; Xiaocen Wang; Lin Tong; Yuanlin Song
Journal:  Clin Respir J       Date:  2022-08-04       Impact factor: 1.761

Review 7.  Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.

Authors:  Sara Gredmark-Russ; Cecilia Söderberg-Nauclér
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

8.  Rapid reconstitution of regulatory T-cell subsets is associated with reduced rates of acute graft-versus-host disease and absence of viremia after cord blood transplantation in children with reduced-intensity conditioning using alemtuzumab.

Authors:  Xiaohua Chen; Memphis Hill; Mark Vander Lugt; Maria Escolar; Zhou Fang; Wei Chen; Paul Szabolcs
Journal:  Cytotherapy       Date:  2020-02-21       Impact factor: 6.196

9.  CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations.

Authors:  Hiroshi Takahashi; Kazuhiko Ikeda; Kazuei Ogawa; Syunnichi Saito; Alain M Ngoma; Yumiko Mashimo; Koki Ueda; Miki Furukawa; Akiko Shichishima-Nakamura; Hiroshi Ohkawara; Kenneth E Nollet; Hitoshi Ohto; Yasuchika Takeishi
Journal:  Biol Res       Date:  2015-07-26       Impact factor: 5.612

Review 10.  Oral complications in hematopoietic stem cell recipients: the role of inflammation.

Authors:  T M Haverman; J E Raber-Durlacher; W M H Rademacher; S Vokurka; J B Epstein; C Huisman; M D Hazenberg; J J de Soet; J de Lange; F R Rozema
Journal:  Mediators Inflamm       Date:  2014-04-10       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.